CIK: 1455740 - Address: C/O Acura Pharmaceuticals, Inc., 616 N. North Court, Suite 120, Palatine, IL 60067
5 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

P%ret113133-16-48-39-16
P%wins6710067330044

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

12/15/17 16:28
12/14/17
ACURAcura Pharmaceuticals, IncNYHealthDrugPharmaceutical PreparationsBrzeczko Albert WILOVP TechnP300.10000300999%316D
8/29/17 16:12
8/25/17
ACURAcura Pharmaceuticals, IncNYHealthDrugPharmaceutical PreparationsBrzeczko Albert WILOVP TechnP.m50.471601120816D
5/19/14 16:00
5/19/14
ACURAcura Pharmaceuticals, IncNYHealthDrugPharmaceutical PreparationsBrzeczko Albert WILOVP TechnP21.2002826D-53-44-27-34-14-8-50-11-11-27-54-34
11/26/13 08:00
11/25/13
ACURAcura Pharmaceuticals, IncNYHealthDrugPharmaceutical PreparationsBrzeczko Albert WILOVP TechnP21.7001524D-4839-2711-2-52224222-35-69
5/18/12 16:06
5/18/12
ACURAcura Pharmaceuticals, IncNYHealthDrugPharmaceutical PreparationsBrzeczko Albert WILOVP TechnP32.5501523D-25-41-37-21-22-20-1113518-44-56-13

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact